José Arquímides Castro Del Pino

Technical

Effects of Tank-Agitated Fermentation on Therapeutic mAb Quality

1 March 2020

Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1  and chronic conditions such as cancer

1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061